Effectiveness of Dupilumab in the Treatment of Patients with Uncontrolled Severe CRSwNP: A “Real-Life” Observational Study in Naïve and Post-Surgical Patients
<b><i>Background</i></b>: Chronic rhinosinusitis with nasal polyps (CRSwNP) represents 25–30% of all CRS cases, and in the most severe forms it is associated with a poor quality of life and a high rate of nasal polyps’ recurrence after surgery. Dupilumab has been suggested as...
Main Authors: | Giancarlo Ottaviano, Tommaso Saccardo, Giuseppe Roccuzzo, Riccardo Bernardi, Alessandra Di Chicco, Alfonso Luca Pendolino, Bruno Scarpa, Edoardo Mairani, Piero Nicolai |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-09-01
|
Series: | Journal of Personalized Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-4426/12/9/1526 |
Similar Items
-
Measuring Nasal Patency and the Sense of Smell in CRSwNP Patients Treated with Dupilumab
by: Giancarlo Ottaviano, et al.
Published: (2023-01-01) -
Effectiveness of Dupilumab in the Treatment of Adult and Older Adult Patients with Severe, Uncontrolled CRSwNP
by: Giancarlo Ottaviano, et al.
Published: (2023-08-01) -
Olfaction Recovery following Dupilumab Is Independent of Nasal Polyp Reduction in CRSwNP
by: Elena Cantone, et al.
Published: (2022-07-01) -
Correlations between Peak Nasal Inspiratory Flow, Acoustic Rhinometry, 4-Phase Rhinomanometry and Reported Nasal Symptoms
by: Giancarlo Ottaviano, et al.
Published: (2022-09-01) -
Rapid and Continuing Improvements in Nasal Symptoms with Dupilumab in Patients with Severe CRSwNP
by: Bachert C, et al.
Published: (2022-05-01)